4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Wai Chun Bio-Technology Limited (0660) operates in the Chemicals industry and is headquartered in Wan Chai, Hong Kong with about 63 employees. Its market capitalization is roughly HK$165 million. In the fiscal year ended 2025-06-30, 0660 reported HK$377M in revenue and (HK$15M) in net income.
Wai Chun Bio-Technology Limited, an investment holding company, engages in the manufacture and sale of modified starch and other biochemical products in the People's Republic of China.
Interactive charts & full statements → Open the 0660 valuation workbench →
| Income statement | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2021-12-31 |
|---|---|---|---|---|
| Total Revenue | HK$377M | HK$370M | HK$774M | HK$495M |
| Gross Profit | HK$36M | HK$34M | HK$50M | HK$38M |
| Operating Income (EBIT) | HK$1M | HK$1M | HK$14M | HK$2M |
| Net Income | (HK$15M) | (HK$44M) | (HK$15M) | (HK$17M) |
HKD; HK$M / HK$B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | HK$215M | HK$210M | HK$240M | HK$250M | — |
| Total Liabilities | HK$277M | HK$265M | HK$230M | HK$244M | — |
HKD; HK$M / HK$B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 0660 viewer.
About TickerBase · Data methodology & sources · Privacy · Terms